| abstract |
There are provided novel compounds of formula (I) wherein D represents alkyl C1 to 6; T represents a C3-5 saturated or unsaturated alkylene chain substituted by -(CH2)m-NXY; -O-(CH2)2-NH- substituted by -(CH2)m-NXY; or -U-(CH2)a-N(X)-(CH2)b-; and a, b, m, X and Y are as defined in the specification together with processes for their preparation, compositions containing them and their use in therapy. Compounds of formula (I) are expected to be useful inter alia in the treatment of neurodegenerative disorders. |